Eisai to begin administering new Alzheimer’s drug in China, expects significant growth in 2025
On February 4, the major pharmaceutical company Eisai aims to start giving lecanemab, a new Alzheimer’s disease drug developed jointly with the US company Biogen, to 1,500 people in China by the end of the year. In this photo, a scientist looks at a brain scan at a university hospital in Geneva, Switzerland. The picture […]